stockrowKoninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) Operating cash flow
Koninklijke Philips N.V.'s operating cash flow for fiscal 2025 was $1.3B, down 21.9% from $1.7B in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.9B. Over the past ten years it has ranged from −$182.3M (fiscal 2022) to $3.2B (fiscal 2020); the current reading is higher than 27% of that period. Koninklijke Philips N.V. ranks 6th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.3B | (21.90%) |
| FY2024 | $1.7B | (26.56%) |
| FY2023 | $2.3B | — |
| FY2022 | −$182.3M | — |
| FY2021 | $1.9B | (39.24%) |
| FY2020 | $3.2B | 39.45% |
| FY2019 | $2.3B | 8.21% |
| FY2018 | $2.1B | (0.54%) |
| FY2017 | $2.1B | 0.32% |
| FY2016 | $2.1B | 62.59% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $619.5M | 42.19% |
| Jun 2026 | $435.7M | 98.03% |
| Mar 2026 | $220.0M | (86.09%) |
| Dec 2025 | $1.6B | 334.82% |
| 24 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BSX Boston Scientific Corporation compare | $4.2B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| PHG Koninklijke Philips N.V. | $2.9B |
| GEHC GE HealthCare Technologies Inc. compare | $2.4B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $1.9B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc compare | $1.3B |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement